source
- STAT+: Astellas treatment offers new hope to a devastated rare disease communityAlzheimer's drug rollout letdown, a China-based heart drug startup, and more biotech news from The ReadoutSTAT · 3mo ago↗ source
- Inhibrx delivers ‘differentiated’ cancer drug data; Fractyl starts diabetes gene therapy trialInhibrx, the subject of recent buyout rumors, showed its drug might enhance the effects of Keytruda. Elsewhere, Capricor sued its cell therapy partner and Argenx got a revenue boost.BioPharma Dive · 3mo ago↗ source
- Biotech layoffs are easing, but is the worst over?BioNTech is one of the most recent companies to announce cuts, but the pace of job losses is slowing.BioPharma Dive · 3mo ago↗ source